Wyeth to Challenge Efexor Label Revision
602773
Drug maker Wyeth said Monday that it will challenge British regulators&#39; decision to revise the label for its Efexor anti-depressant to state that patients with heart disease should not take the medication.
55690
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's  and Schering-Plough Corp's  popular cholesterol medicine Vytorin after a study showed it was no better than a generic drug in preventing the build-up of fatty plaque.
757758
European medical regulators have called on the worldâs leading pharmaceutical companies to improve their communications with authorities and surveillance of drugs, following frustration about Merckâs handling of the withdrawal of its anti-inflammatory
37763
The US Food and Drug Administration (FDA) announced on Monday that Mifepristoneâs label will be changed to acknowledge that there are risks associated with any abortion, and that physicians prescribing the drug should instruct their patients to contact
270761
Wyeth  said on Monday it will sue Teva Pharmaceuticals USA  for alleged patent infringement and said it received an approvable letter from U.S regulators for bazedoxifene, a drug that helps prevent post-menopausal osteoporosis.
299298
Drugmaker Wyeth said a court in Maryland has granted the company's motion to exclude some expert witnesses from testifying that exposure to thimerosal-containing vaccines can cause autism and rejected the compound's link to autism.
456666
Drugmaker Wyeth WYE.N said on Tuesday  it is in talks with plaintiffs' lawyers to develop a structure  to settle cases of users of recalled diet drugs "fen-phen" who  opted out of a nationwide legal settlement.
477278
Two Philadelphia juries on Wednesday awarded damages to four out of five plaintiffs who argued that Wyeth&#39;s (WYE.N: Quote, Profile, Research) weight-loss drug used as part of the fen-phen combination caused heart-valve damage, the
287949
Purdue Pharma, the maker of OxyContin, said it would begin shipments of the tagged medication this week. Pfizer, the maker of Viagra, said it would begin shipping RFID-tagged bottles by the end of next year.
604135
Wyeth said on Monday it was recalling  several of its Robitussin cough, cold and congestion products  and its Children's Dimetapp Cold & Chest Congestion medicine  because their dosage cups lack a measurement mark for young  children.
566909
The FDA decides to debate the company's lead drug.
377721
Faced with the threat of generic competition, the company focuses its efforts on a new drug.
506735
Wyeth launches a generic version of its own drug.
362336
By Thomas Ginsberg, The Philadelphia Inquirer  Dec. 19--Wyeth Pharmaceuticals said today that the FDA has agreed to conduct a fast-track review of the company's new kidney cancer-fighting drug, Torisel.
732137
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc and Schering-Plough's cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
692821
The arthritis drug Bextra will begin carrying a warning on the label about possible heart and blood-clotting problems, the Food and Drug Administration said yesterday.
614727
The FDA is about to make it harder for drug-eluting stents to win its approval.